1-(1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl)-3-(naphthalen-1-yl)urea

ID: ALA522387

Cas Number: 1160934-70-2

PubChem CID: 25174101

Max Phase: Preclinical

Molecular Formula: C24H25N5O

Molecular Weight: 399.50

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(N)c2)n1

Standard InChI:  InChI=1S/C24H25N5O/c1-24(2,3)21-15-22(29(28-21)18-11-7-10-17(25)14-18)27-23(30)26-20-13-6-9-16-8-4-5-12-19(16)20/h4-15H,25H2,1-3H3,(H2,26,27,30)

Standard InChI Key:  HJWMLCDGRWWLAQ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
    0.5251    2.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1893    1.7038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9038    2.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9038    2.9413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1893    3.3538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5251    2.9413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2396    3.3538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9541    2.9413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9541    2.1163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2396    1.7038    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2396    0.8788    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.5251    0.4663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1893    0.8788    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5251   -0.3587    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1893   -0.7712    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9430   -0.4356    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4950   -1.0487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4018   -1.7830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1360   -0.8762    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2293   -0.1420    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0825   -1.7632    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2756   -1.5917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3375   -2.1437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1221   -1.8888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1660   -2.9507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7791   -3.5027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5637   -3.2478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7352   -2.4408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5199   -2.1858    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
 10  1  2  0
  6  1  1  0
  2  1  1  0
  3  2  2  0
  4  3  1  0
  4  5  2  0
  5  6  1  0
  7  6  2  0
  8  7  1  0
  8  9  2  0
  9 10  1  0
 10 11  1  0
 12 11  1  0
 12 13  2  0
 12 14  1  0
 15 14  1  0
 16 15  2  0
 15 23  1  0
 16 17  1  0
 17 18  1  0
 17 22  2  0
 20 18  1  0
 19 18  1  0
 21 18  1  0
 22 23  1  0
 24 23  1  0
 26 24  2  0
 25 24  1  0
 25 29  2  0
 27 26  1  0
 27 28  2  0
 28 29  1  0
 29 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA522387

   1-[1-(3-Aminophenyl)-3-Tert-Butyl-1h-Pyrazol-5-Yl]-3-Naphthalen-1-Ylurea

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 399.50

Molecular Weight (Monoisotopic): 399.2059

AlogP: 5.55

#Rotatable Bonds: 3

Polar Surface Area: 84.97

Molecular Species: NEUTRAL

HBA: 4

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 11.14

CX Basic pKa: 4.24

CX LogP: 5.39

CX LogD: 5.38

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.39

Np Likeness Score: -1.74

References

1. Getlik M, Grütter C, Simard JR, Klüter S, Rabiller M, Rode HB, Robubi A, Rauh D..  (2009)  Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc.,  52  (13): [PMID:19462975] [10.1021/jm9002928]

2. Klüter S, Grütter C, Naqvi T, Rabiller M, Simard JR, Pawar V, Getlik M, Rauh D..  (2010)  Displacement assay for the detection of stabilizers of inactive kinase conformations.,  53  (1): [PMID:19928858] [10.1021/jm901297e]

3. Simard JR, Klüter S, Grütter C, Getlik M, Rabiller M, Rode HB, Rauh D..  (2009)  A new screening assay for allosteric inhibitors of cSrc.,  5  (6): [PMID:19396179] [10.1038/nchembio.162]

4. Richters A, Nguyen HD, Phan T, Simard JR, Grütter C, Engel J, Rauh D..  (2014)  Identification of type II and III DDR2 inhibitors.,  57  (10): [PMID:24754677] [10.1021/jm500167q]

Source

Source(1):

• Scientific Literature